We are a new group at Fiocruz (Brasil) that wants to try to produce recombinant transglutaminase from Streptomyces sp. for biocatalysis. However, I am really surprised that even when there are a lot of microbial transglutaminases ( http://www.ncbi.nlm.nih.gov/protein/?term=transglutaminase), industry and research groups mainly use that from Streptomyces. Could anyone help me or advise why this happens? I am really curious because maybe it could be possible to try to express another mTG more easily or with different specificities and properties.